CalciMedica is trading 5.53% down at $2.05, with no clear company-specific catalyst identified for September 8, 2026.
- CalciMedica announced participation in the H.C. Wainwright conference on September 15, but the announcement does not explain the decline.
- Broader market weakness likely added pressure, with the Nasdaq down 0.52% and Dow down 1.04%.